Clinical Trial Search

Primary: The Primary Efficacy Outcome of the Study is Response to Treatment Which Will be Assessed at the End of Therapy. Successful Response to Treatment is Defined as…

Primary: Number of Participants With a Catheter Associated Urinary Tract Infection (CAUTI) — 7; 6 Participants

Primary: Rate of Catheter-associated Urinary Tract Infection — 10; 12 infections per 1000 days

Primary: Post-operative Urinary Tract Infection — 19; 20 Participants

Primary: Number of Participants Experiencing Urinary Tract Infection Within 6 Weeks of Surgery — 13; 13 Participants — p=0.97

Primary: Rate of UTI While Colonized With E. Coli 83972. — 8.5 UTIs per 1000 patient-days

Primary: Number of Participants With Appropriate Treatment — 31; 23 Participants — p=0.45

Primary: Total Bacteria Count Change From Baseline and After 24 Hours. — -62519; 57448 CFU/mL — p=0.6250

Primary: Urinary Tract Infection Rate — 24; 29 Participants — p=0.30

Primary: To Evaluate the Effect of Oral Supplementation With Lactobacillus Reuteri on the Frequency of Confirmed UTI in Adult Women With Recurrent UTI. — 1.2; 1.3 Number of…

Primary: Occurrence of Symptomatic Urinary Tract Infections (UTIs) — 19; 20; 2; 0 participants — p=0.0383

Primary: UTI — 15; 14 Participants — p=0.84

Primary: Urinary Tract Infection After Percutaneous Nephrostomy Procedure — 5; 10 Percutaneous nephrostomy procedure — p=0.548

Primary: Participants With Clinically-diagnosed and Treated UTI's. — 15; 30 participants

Primary: Participants With Urine Cultures With Bacteriuria (>100,000 Cfu/ml or >=100,000 Cfu/ml) Plus Pyuria (Any WBC) — 26; 32; 21; 27 participants

Primary: Urinary Tract Infection — 11; 12 UTI

Primary: Evaluate Bladder Storage Using Urodynamics — 611; 177.67; 662; 452 mL

Primary: Treatment of Clinically Suspected UTI - Using Intent to Treat Analysis — 13; 12 Participants

Primary: Number of Participants With Acute Urinary Retention — 6; 7 Participants

Primary: Infections Per 1,000 (CAUTI) Days — 0.8429 infection per 1,000 catheter days

Primary: Bladder Colonization — 62 percentage of participants

Primary: Number of Urinary Tract Infections (UTI) Over Time — 0.53; 0.09 UTI events per person months. — p=<0.0001

Primary: The Incidence of UTI — 66; 54 Participants — p=0.299

Primary: Number of Patients Developing BK Infection at 6 Months Post-transplant — 25; 5 Participants

Primary: Number of Patients Who Developed Postoperative Urinary Retention (POUR), Unable to Void a Volume Greater Than or Equal to 30ml/hr — 4; 5 Participants

Primary: Percentage of Cases Who Received Excessive Post-procedural Antimicrobials — 216; 644 Participants — p=0.004

Primary: Proportion of Asymptomatic Bacteriuria Treated With Antibiotics and Urinary Tract Infection Treated With Antibiotics — 31; 25 Participants

Primary: Number of Participant With Urinary Tract Infection — 12; 13 Participants

Primary: Favorable Clinical Outcomes (FCl) — 170; 132 Participants

Primary: Number of Subjects With Combined Clinical and Microbiologic Response — 70 Participants